Evidence map›Paper›PMID 42297918›Full record

ArticleLeukemia2026

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study.

Simon Renders, Maud Ngoya, Laurence de Leval, Herve Finel, Irma Khvedelidze, Rachael Pocock, Ron Ram, Tobias Gedde-Dahl, Yasmina Serroukh, Gesine Bug and 15 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Simon RendersHeidelberg University Hospital, Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg, Germany. simon.renders@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0001-7883-2956
Maud NgoyaLymphoma Working Party, European Society for Blood and Marrow Transplantation Central Registry Office, Paris, France.
Laurence de LevalInstitute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.ORCID http://orcid.org/0000-0003-3994-516X
Herve FinelLymphoma Working Party, European Society for Blood and Marrow Transplantation Central Registry Office, Paris, France.
Irma KhvedelidzeLymphoma Working Party, European Society for Blood and Marrow Transplantation Central Registry Office, Paris, France.
Rachael PocockUniversity College London Hospitals NHS Foundation Trust, London, UK.
Ron RamBMT Unit, Tel Aviv Sourasky Medical Centre, and Tel Aviv University, Tel Aviv, Israel.ORCID http://orcid.org/0000-0001-8683-6930
Tobias Gedde-DahlOslo University Hospital, Rikshospitalet, Oslo, Norway.
Yasmina SerroukhErasmus UMC Cancer Institute, Department of Hematology, University Medical Centre, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-8751-5725
Gesine BugGoethe University University Hospital Frankfurt, Dept. of Medicine 2, Frankfurt, Germany.ORCID http://orcid.org/0000-0003-2359-131X
Nicolaus KrögerUniversitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5103-9966
Arnon NaglerChaim Sheba Medical Center, Tel Hashomer, Israel.
Thomas PabstInselspital Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0002-6055-5257
Werner RabitschMedical University of Vienna, Wien, Austria.
Ibrahim Yakoub-AghaCHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France.
Matthias EderHannover Medical School, Hannover, Germany.ORCID http://orcid.org/0009-0000-3362-5814
Siret RatipAcıbadem University, Istanbul, Turkey.
Christoph ScheidUniversity Hospital of Cologne, Department of medicine I, Cologne, Germany.
Jose Antonio Pérez-SimónHospital Universitario Virgen Del Rocío, Instituto de Biomedicina de Sevilla (IBIS/ CSIC), Universidad de Sevilla, Sevilla, Spain.ORCID http://orcid.org/0000-0003-3616-6101
Eva Maria Wagner-DrouetUniversity Hospital Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-0728-2253
Anna SuredaClinic Hematology Department, Institut Català d'Oncologia - L'Hospitalet, Institut d'Investigacions Biomèdiques de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1238-6970
Norbert SchmitzUniversity Hospital Muenster, Münster, Germany.ORCID http://orcid.org/0000-0003-4938-7528
Bertram GlassHELIOS Klinikum Berlin-Buch, Berlin, Germany.
Ali BazarbachiBone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.ORCID http://orcid.org/0000-0002-7171-4997
Peter DregerHeidelberg University Hospital, Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-7429-8570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42297918
PMCPMC13421346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.